Cargando…

Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer

Tumorigenesis and metastasis have deep connections to inflammation and inflammatory cytokines, but the mechanisms underlying these relationships are poorly understood. Leukemia Inhibitory Factor (LIF) and its receptor (LIFR), part of the interleukin-6 (IL-6) cytokine family, make up one such ill-def...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christianson, Joe, Oxford, Julia Thom, Jorcyk, Cheryl L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358831/ https://www.ncbi.nlm.nih.gov/pubmed/34395259 http://dx.doi.org/10.3389/fonc.2021.693724

Ejemplares similares

DICER1 Syndrome: DICER1 Mutations in Rare Cancers
por: Robertson, Jake C., et al.
Publicado: (2018)

Endoplasmic Reticulum Stress and Unfolded Protein Response in Cartilage Pathophysiology; Contributing Factors to Apoptosis and Osteoarthritis
por: Hughes, Alexandria, et al.
Publicado: (2017)

Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
por: Mikelonis, Dawn, et al.
Publicado: (2014)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011)

The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation
por: Goyden, Jake, et al.
Publicado: (2015)

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
por: Di Giorgio, Cristina, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis
por: Di Giorgio, Cristina, et al.
Publicado: (2022)

OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition
por: Covert, Hunter, et al.
Publicado: (2019)

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
por: Sletta, Kristine Yttersian, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer
por: Arienti, Chiara, et al.
Publicado: (2019)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis
por: Hu, Hengfen, et al.
Publicado: (2023)

The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
por: Minutolo, Nicholas G., et al.
Publicado: (2019)

Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
por: García-Ledo, Lucía, et al.
Publicado: (2017)

The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology
por: Zutautas, Katherine B., et al.
Publicado: (2023)

Colony-stimulating Factor 3 Receptor Mutated Chronic Neutrophilic Leukemia: A Rare Case Report
por: Thapa, Bicky, et al.
Publicado: (2018)

The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives
por: Gargiulo, Ernesto, et al.
Publicado: (2023)

F-ATP synthase inhibitory factor 1 regulates metabolic reprogramming involving its interaction with c-Myc and PGC1α
por: Guo, Lishu, et al.
Publicado: (2023)

Leukemia inhibitory factor and its receptor: expression and regulation in the porcine endometrium throughout the estrous cycle and pregnancy
por: Yoo, Inkyu, et al.
Publicado: (2019)

Allogeneic Embryos Disregulate Leukemia Inhibitory Factor (LIF) and Its Receptor in the Porcine Endometrium During Implantation
por: Cambra, Josep M., et al.
Publicado: (2020)

YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer
por: Hergovich, Alexander
Publicado: (2012)

Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma
por: Yuan, Xiaofeng, et al.
Publicado: (2022)

Hypoxia and Hypoxia-Inducible Factors in Leukemias
por: Deynoux, Margaux, et al.
Publicado: (2016)

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective
por: Kwok, Marwan, et al.
Publicado: (2021)

Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors
por: Thomas, L Michael
Publicado: (2015)

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
por: Kennedy, Vanessa E., et al.
Publicado: (2020)

Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022)

Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer
por: Jorgensen, Megan M., et al.
Publicado: (2022)

Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
por: Huang, Jian, et al.
Publicado: (2022)

Cost-Effectiveness of Tucatinib in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer From the US and Chinese Perspectives
por: Wu, Qiuji, et al.
Publicado: (2020)

Hypoxic stress and hypoxia-inducible factors in leukemias
por: Magliulo, Daniela, et al.
Publicado: (2022)

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia
por: Nicolò, Antonella, et al.
Publicado: (2021)

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer
por: Angarita, Ana Milena, et al.
Publicado: (2016)

The Emerging Role of Platelets in the Formation of the Micrometastatic Niche: Current Evidence and Future Perspectives
por: Gkolfinopoulos, Stavros, et al.
Publicado: (2020)

Polarized secretion of Leukemia Inhibitory Factor
por: Hill, Eric J, et al.
Publicado: (2008)

Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021)

Artemin and Its Emerging Role in Pathogenesis of Systemic Tumors Besides Pancreatic Cancers
por: Kapoor, Shailendra
Publicado: (2012)

The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties
por: Wei, Dingju, et al.
Publicado: (2022)

The Emerging Roles of Rad51 in Cancer and Its Potential as a Therapeutic Target
por: Wang, Ziyi, et al.
Publicado: (2022)

Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uf3t6hmr33jf9u5evkn453m5mo